Study of New Determinants of Type 2 Diabetes in Severe Obesity
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 270
- 试验地点
- 2
- 主要终点
- comparison of proteins levels
研究概览
简要总结
This project aims at identifying new determinants of type 2 diabetes in severe obesity. To do so, a biological collection, including tissues of interest in the field of metabolism, will be collected during bariatric surgery in obese patients. Three different groups of metabolic status of patients, corresponding to different stages of evolution of the disease, will be constituted: type 2 diabetes, insulin resistance, insulin sensitivity.
The main objective is to compare, between these 3 groups of patients, several biological processes that may be involved in the pathophysiology of type 2 diabetes and disorders associated with obesity, including:
- Abnormalities of the transcriptome, proteome, metabolome in all target tissues (plasma, serum, muscle, subcutaneous and visceral adipose tissue, omental artery, liver)
- Identification of metabolic signatures, protein and miRNA in plasma
- Immunoinflammatory response in adipose tissue
- Polymorphisms SNP from whole blood
- Histological analysis of tissue sections This main objective will be studied on samples taken at the time of surgery Secondary objectives will be to study the changes in metabolites, proteins and miRNA in plasma level 3 and 12 months after the completion of surgery, according to the initial metabolic state.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Written informed consent
- •Age 18 - 65 years inclusive at surgery
- •Subject qualified for bariatric surgery (sleeve gastrectomy or gastric bypass)
- •Specific criteria :
- •Type 2 diabetes group (D) (90 patients) : type 2 diabetes according to ADA criteria
- •Insulin resistance non diabetes group (IR) (80 patients) : HOMA-IR criteria ≥ 3
- •Insulin Sensitivity non diabetes group (N) (100 patients) : N1.HOMA-IR criteria < 3
- •Non inclusion Criteria:
- •Vulnerability according to article L1121-6 of the Public Health Code
- •Protected adult or unability to give consent according to article L1121-8 of the Public Health Code
- •Unability to understand the design and aims of the study or to communicate with the investigator
- •Non affiliation to a social security system
- •Prior bariatric surgery (except lap-band procedure)
- •Serologic profile indicating hepatitis B, hepatitis C or HIV infection
- •Inflammatory, infectious or autoimmune disease (current or in the previous 3 month)
- •Malignancies within 5 years prior to inclusion or not considered as treated curatively
- •Concomitant use of steroids or NSAI or use in the 8 days before surgery
- •alcohol abuse/addiction
- •Anticipated poor compliance to study procedures
- •Other type of diabetes than type 2
排除标准
- •Cancelled bariatric surgery
- •Tissue collection not possible during the bariatric surgery
结局指标
主要结局
comparison of proteins levels
时间窗: At baseline (day of surgery)
in liver, muscle, adipose tissue and plasma according to metabolic state
comparison of metabolites
时间窗: At baseline (day of surgery)
comparison of miRNA
时间窗: At baseline (day of surgery)
in liver, muscle, adipose tissue and plasma according to metabolic state
次要结局
- changes in proteins in plasma level(3 and 12 months after the completion of surgery)
- changes in metabolites in plasma level(3 and 12 months after the completion of surgery)
- changes in miRNA in plasma level(3 and 12 months after the completion of surgery)